The Charter Court is asked whether a longer life can cost you your office

The question before the court, once the pleadings are stripped of their heat, is narrow. Its narrowness deserves respect. Not: should Justice Aurelio Vance, one hundred and thirty years old and one hundred and thirty years on this bench, step down. Only this — may a polity lawfully condition access to a scarce medical therapy on the surrender of public office. Two questions, and nearly all of the public fury lives in the gap between them.

The petition arrived here from the coast, filed by would-be successors and clerks after the Meridian Longevity Institute's eleven-member panel adjourned without adopting the 'renewal-value' criteria it convened to weigh. The panel could not agree. The petitioners now ask the court to say what the panel would not. They want a rule before the next Assembly session convenes. Absent one, the matter falls to custom, and custom, in an age when incumbents decline to age, has been writing itself in the corridor outside Vance's chambers for six weeks.

First, define the term at issue. 'Renewal value' is the proposed metric by which an applicant on the coastal cohort waitlist — forty thousand names, advanced 1.9 percent last quarter — would move faster in exchange for a pledge to vacate a post. The institute's senior counsel warned, in a memo circulated before the panel sat, that conditioning therapy on resignation may violate the Accord's equal-access clause. That memo is now Exhibit One.

Second, the precedent. The court has held since the Accord that access to shared infrastructure may not be dimmed to compel a political act. The beam ruling this desk covered last quarter turned on exactly that principle. A therapy is not a beam. But the petitioners argue the logic travels: a benefit withheld to extract a resignation is a benefit weaponized, whatever the benefit happens to be.

Third, the counterargument, and it isn't trivial. Counsel for the institute contends that a waitlist is not a right but an allocation, and that a polity may lawfully prefer applicants who agree to renew its institutions. Bioethicists call this dignified turnover. The difficulty, raised sharply at the bar, is definitional: who defines renewal value, and how long before the metric becomes a patronage instrument, advancing the compliant and stranding the inconvenient. A rule that purges dissenters by another name would not survive equal-access review. A rule that merely rewards voluntary departure might.

Vance is not a party, but her shadow governs the file. She has answered the sit-in — thirty-one occupants of the Annex floor, six weeks running — not with a resignation date but with a proposal for a phased docket handover: junior justices drafting selected matters while she retains final signature and her seat. No date attached. The petitioners read that offer as the very problem they asked the court to solve.

Seven of the eleven Meridian panelists have already received tier-one therapy. None has disclosed placement on any waitlist. The court has set no date for argument.